<i>In Silico</i> Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use DisorderAlireza Sharafshah, Kenneth Blum, Rossano Kepler Alvim Fiorelli et al.|Current Neuropharmacology|2025Cited by 9